Effect of essential fatty acids by MCP-1/TGF-β<sub>1</sub>/COL-Ⅰ pathways for human kidney 2 cells with sugar damage

JIANG Mingxia; WANG Yu; LYU Guilan; ZHOU Yinan; DONG Xingyuan; XU Qi; ZHENG Jinfeng

doi:10.7619/jcmp.20220397

Journal of Clinical Medicine in Practice > 2022 > 26(13): 1-6, 40. > DOI: 10.7619/jcmp.20220397

JIANG Mingxia, WANG Yu, LYU Guilan, ZHOU Yinan, DONG Xingyuan, XU Qi, ZHENG Jinfeng. Effect of essential fatty acids by MCP-1/TGF-β₁/COL-Ⅰ pathways for human kidney 2 cells with sugar damage[J]. Journal of Clinical Medicine in Practice, 2022, 26(13): 1-6, 40. DOI: 10.7619/jcmp.20220397

Citation:

PDF (2634 KB)

Effect of essential fatty acids by MCP-1/TGF-β₁/COL-Ⅰ pathways for human kidney 2 cells with sugar damage

1.
Department of Nutrition, General Hospital of East Theatre Command of Chinese People′s Liberation Army, Nanjing, Jiangsu, 210002
2.
National Clinical Research Center for Kidney Disease, General Hospital of East Theatre Command of Chinese People′s Liberation Army, Nanjing, Jiangsu, 210002

More Information

Received Date: February 09, 2022
Available Online: July 01, 2022

Graphical Abstract

Abstract

Abstract

Objective
To study the effect and mechanism of monocyte chemotactic protein-1 (MCP-1)/transforming growth factor beta1(TGF-β₁)/collagen-Ⅰ (COL-Ⅰ) pathways for human kidney 2 (HK-2) cells induced by high glucose.
Methods
Methyl Thiazolyl Tetrazolium (MTT) method was used to establish HK-2 cell model damaged by sugar. The protein expression levels of MCP-1, TGF-β₁ and COL-Ⅰ in supernatant of HK-2 cells were determined by enzyme-linked immunosorbent assay (ELISA), and the expressions of MCP-1 , TGF-β₁ and COL-ⅠmRNA in HK-2 cells were determined by reverse transcription-polymerase chain reaction (RT-PCR) after treatment with different concentrations of alpha linolenic acid (ALA)/linoleic acid (LA).
Results
After 48 h intervention in HK-2 cells induced by glucose were treated with 50 μmol/L ALA and LA and 50 μmol/L mixture of ALA/LA with the ratio of 1 to 4, the expression levels of MCP-1mRNA and MCP-1 protein were significantly decreased (P < 0.05). After HK-2 cells induced by glucose and treated with 100 μmol/L ALA and LA for 48 h, TGF-β₁mRNA and TGF-β₁ protein expression were significantly decreased(P < 0.05). After HK-2 cells induced by glucose and treated with 100 μmol/L ALA, 50 μmol/L LA and 50 μmol/L mixture of ALA/LA with the ratio of 1 ∶ 4 for 48 h, the expression of COL-Ⅰ mRNA and COL-Ⅰ protein were significantly decreased (P < 0.05).
Conclusion
HK-2 cells are damaged by high glucose, manifesting as increased expression of cytokines MCP-1 and TGF-β₁, and increased expression of fibrosis product COL-Ⅰ. ALA/LA can down-regulate the expression of MCP-1 and TGF-β₁, reduce the level of COL-Ⅰ, and protect HK-2 cells damaged by glucose.

FullText(HTML)

References (15)

References

[1]	DRISS V, QUESNEL B, BRINSTER C. Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to Thymus atrophy in acute myeloid leukemia[J]. Eur J Immunol, 2015, 45(2):396-406. doi: 10.1002/eji.201444736
[2]	SULAIMAN W, NGUYEN D H. Transforming growth factor beta 1, a cytokine with regenerative functions[J]. Neural Regen Res, 2016, 11(10):1549-1552. doi: 10.4103/1673-5374.193223
[3]	DOCHERTY N G, MURPHY M, MARTIN F, et al. Targeting cellular drivers and counter-regulators of hyperglycaemia- and transforming growth factor-β1-associated profibrotic responses in diabetic kidney disease[J]. Exp Physiol, 2014, 99(9):1154-1162. doi: 10.1113/expphysiol.2014.078774
[4]	WU L, LI X Q, CHANG D Y, et al. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease[J]. Nephrol Dial Transplant, 2020, 35(2):291-297.
[5]	ZENI L, NORDEN A G W, CANCARINI G, et al. A more tubulocentric view of diabetic kidney disease[J]. J Nephrol, 2017, 30(6):701-717. doi: 10.1007/s40620-017-0423-9
[6]	SHUI H, GAO P, SI X Y, et al. Mycophenolic acid inhibits albumin-induced MCP-1 expression in renal tubular epithelial cells through the p38 MAPK pathway[J]. Mol Biol Rep, 2010, 37(4):1749-1754. doi: 10.1007/s11033-009-9599-y
[7]	JIANG M X, ZHANG H F, ZHAI L J, et al. ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway[J]. Lipids Heal Dis, 2017, 16(1):216. doi: 10.1186/s12944-017-0611-6
[8]	姜明霞, 章海风, 叶变良, 等. 葡萄糖对HK-2细胞的糖毒性及ALA/LA的干预作用[J]. 营养学报, 2017, 39(1):41-44, 49. https://www.cnki.com.cn/Article/CJFDTOTAL-YYXX201701011.htm
[9]	COUSIN S P, HVGL S R, WREDE C E, et al. Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1[J]. Endocrinology, 2001, 142(1):229-240. doi: 10.1210/endo.142.1.7863
[10]	SURESH Y, DAS U N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus:effect of ω-6 fatty acids[J]. Nutrition, 2003, 19(2):93-114. doi: 10.1016/S0899-9007(02)00856-0
[11]	HALLER H, BERTRAM A, NADROWITZ F, et al. Monocyte chemoattractant protein-1 and the kidney[J]. Curr Opin Nephrol Hypertens, 2016, 25(1):42-49. doi: 10.1097/MNH.0000000000000186
[12]	MORIYA T, TANAKA K, MORIYA R. Glomerular structural changes and structural-functional relationships at early stage of diabetic nephropathy in Japanese type 2 diabetic patients[J]. Med Electron Microsc, 2000, 33(3):115-122. doi: 10.1007/s007950000010
[13]	陈继业, 余雪松, 叶本兰. TGF-β1与糖尿病肾病[J]. 中国糖尿病杂志, 2002, 10(1):56-58. doi: 10.3321/j.issn:1006-6187.2002.01.015
[14]	LEE S B, KALLURI R. Mechanistic connection between inflammation and fibrosis[J]. Kidney Int Suppl, 2010(119):S22-S26.
[15]	SATIRAPOJ B, DISPAN R, RADINAHAMED P, et al. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease[J]. BMC Nephrol, 2018, 19(1):246. doi: 10.1186/s12882-018-1043-x

Cited By

Cited by

Periodical cited type(25)

1.	刘珊励，刘金叶，陈叶奇. 甘精胰岛素与预混胰岛素分别联合阿卡波糖对2型糖尿病患者血糖控制及胰岛素用量的影响. 糖尿病新世界. 2024(15): 91-94 .
2.	佘其美，董亚苒，王新芳，玉晓露，程景丽，裴倩倩，谷贵燕，李湘. 分析甘精胰岛素联合磷酸西格列汀治疗老年2型糖尿病（T2DM）的临床效果. 糖尿病新世界. 2023(04): 116-119+123 .
3.	魏伟. 甘精胰岛素联合重组人胰岛素强化治疗2型糖尿病的临床效果. 临床合理用药. 2023(23): 98-101 .
4.	毛财凤. 甘精胰岛素联合口服降糖药治疗血糖控制不佳的2型糖尿病患者的临床效果. 中国医学创新. 2023(25): 16-20 .
5.	郑清华，时维琼，刘慧丽. 胰岛素联合平衡盐溶液对老年重度糖尿病酮症酸中毒患者β2微球蛋白、FT4水平的影响. 中国老年学杂志. 2022(08): 1816-1819 .
6.	刘利. 利格列汀联合度拉糖肽对2型糖尿病患者临床疗效研究. 天津药学. 2022(02): 63-65+71 .
7.	陈钦榜，何英. 阿卡波糖联合甘精胰岛素对2型糖尿病患者的疗效及不良反应的影响. 糖尿病新世界. 2022(13): 81-84 .
8.	张魁星. 甘精胰岛素联合二甲双胍治疗2型糖尿病的效果分析. 现代诊断与治疗. 2022(18): 2717-2719 .
9.	张子毅，郭静超. 甘精胰岛素联合二甲双胍对初发2型糖尿病患者血糖水平和胰岛β功能的影响. 实用糖尿病杂志. 2021(01): 99-100 .
10.	王利平. 阿卡波糖和胰岛素治疗老年2型糖尿病的效果和安全性. 中国当代医药. 2021(11): 76-78 .
11.	冯聪. 2型糖尿病应用长效胰岛素联合口服降糖药治疗的有效性研究. 中国实用医药. 2021(20): 136-138 .
12.	黄新峰. 2型糖尿病治疗中甘精胰岛素联合瑞格列奈的应用安全性分析. 黑龙江中医药. 2021(04): 35-36 .
13.	房思思. 长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性. 中国实用医药. 2021(27): 114-116 .
14.	汪俊. 甲巯咪唑联合甘精胰岛素对糖尿病伴甲亢的疗效分析. 医学食疗与健康. 2021(08): 58-59 .
15.	李华荣，余婷. 麦味地黄汤加减联合消渴丸治疗2型糖尿病临床效果观察. 现代诊断与治疗. 2021(21): 3380-3381 .
16.	林小玲. 甘精胰岛素联合阿卡波糖治疗老年糖尿病的临床疗效及安全性分析. 中国现代药物应用. 2020(09): 170-171 .
17.	陈维平，谢芸. 沙格列汀联合胰岛素用药在2型糖尿病治疗中的临床作用. 中外医学研究. 2020(15): 136-138 .
18.	何德卓. 甘精胰岛素联合阿卡波糖治疗2型糖尿病临床观察. 北方药学. 2020(06): 104-105 .
19.	张明谦. 甘精胰岛素和预混胰岛素治疗2型糖尿病的临床效果比较. 福建医药杂志. 2020(03): 174-175 .
20.	林玉平. 甘精胰岛素联合门冬胰岛素治疗对T2DM患者的血糖控制效果. 海峡药学. 2020(08): 190-192 .
21.	龙爱梅，武红梅，邓丽萍，黄妙玲，何圣清，张帆. 甘精胰岛素和预混胰岛素分别联合阿卡波糖治疗2型糖尿病效果差异. 中国处方药. 2020(10): 105-106 .
22.	王玲，赵岚. 糖尿病患者阿卡波糖治疗的临床疗效研究进展. 实用心脑肺血管病杂志. 2020(S1): 282-283 .
23.	孙景. 甘精胰岛素联合瑞格列奈治疗2型糖尿病的价值研究. 海峡药学. 2020(10): 155-156 .
24.	张琼珍. 预混胰岛素类似物与基础胰岛素对128例2型糖尿病患者起始胰岛素治疗的临床疗效分析. 糖尿病新世界. 2020(22): 34-36 .
25.	何燕. 基础胰岛素联合阿卡波糖对比预混胰岛素治疗2型糖尿病的临床效果分析. 糖尿病新世界. 2020(24): 94-96 .

Other cited types(0)

Get Citation

PDF

XML

Article views (261) PDF downloads (30) Cited by(25)

Turn off MathJax

Article Contents

Abstract

References

Effect of essential fatty acids by MCP-1/TGF-β1/COL-Ⅰ pathways for human kidney 2 cells with sugar damage

Abstract

References

Cited by

Periodical cited type(25)

Other cited types(0)

Catalog

Export File

Citation

Format

Content

Effect of essential fatty acids by MCP-1/TGF-β₁/COL-Ⅰ pathways for human kidney 2 cells with sugar damage